Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Andes

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|June 15, 2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance NetworkShawn R Lockhart, Alicia J Zimbeck, John W Baddley, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
In memoriam: William A. CraigUrsula Theuretzbacher, Paul G Ambrose, Alasdair P MacGowan, et al.
Infection and Immunity|April 2, 2025
<i>Candida albicans</i> biofilm extracellular vesicles deliver candidalysin to epithelial cell membranes and induce host cell responsesSejeong Lee, Antzela Tsavou, Robert Zarnowski, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief SummarySujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Journal of Clinical Microbiology|May 13, 2011
Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Shawn R Lockhart, Debra Wagner, Naureen Iqbal, et al.
Nature Communications|March 4, 2025
Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicansEmily Puumala, Meganathan Nandakumar, Bonnie Yiu, et al.
Eukaryotic Cell|May 3, 2011
Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensisYing-Lien Chen, Alexandra Brand, Emma L Morrison, et al.
Mbio|April 11, 2013
Regulatory role of glycerol in Candida albicans biofilm formationJigar V Desai, Vincent M Bruno, Shantanu Ganguly, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2020
Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tubeErin K McCreary, M Hong Nguyen, Matthew R Davis, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|June 15, 2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance NetworkShawn R Lockhart, Alicia J Zimbeck, John W Baddley, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2015
In memoriam: William A. CraigUrsula Theuretzbacher, Paul G Ambrose, Alasdair P MacGowan, et al.
Infection and Immunity|April 2, 2025
<i>Candida albicans</i> biofilm extracellular vesicles deliver candidalysin to epithelial cell membranes and induce host cell responsesSejeong Lee, Antzela Tsavou, Robert Zarnowski, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief SummarySujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Open Forum Infectious Diseases|November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Journal of Clinical Microbiology|May 13, 2011
Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006Shawn R Lockhart, Debra Wagner, Naureen Iqbal, et al.
Nature Communications|March 4, 2025
Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicansEmily Puumala, Meganathan Nandakumar, Bonnie Yiu, et al.
Eukaryotic Cell|May 3, 2011
Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensisYing-Lien Chen, Alexandra Brand, Emma L Morrison, et al.
Mbio|April 11, 2013
Regulatory role of glycerol in Candida albicans biofilm formationJigar V Desai, Vincent M Bruno, Shantanu Ganguly, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2020
Achievement of clinical isavuconazole blood concentrations in transplant recipients with isavuconazonium sulphate capsules administered via enteral feeding tubeErin K McCreary, M Hong Nguyen, Matthew R Davis, et al.
Pageof 21